Company / Revenue
Valion Bio, Inc. Revenue History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$1.2M
FY2024
5-year range
$1.2M / $1.8M
FY2022-FY2024
Trend
-36.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $1M to $1M over the past 2 years.
Based on SEC 10-K filings.
$1M in FY2024.
Declined from $1M to $1M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, revenue decreased 36.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -10.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.2M | -36.1% |
| FY2023 | $1.8M | +46.4% |
| FY2022 | $1.3M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026